2021 Meeting Agenda (All Times Pacific)Register Now

Wednesday, November 3, 2021

8:30

Meet the Professor: Use of CGM in the Hospital

Guillermo Umpierrez, MD
Emory University, Atlanta, Georgia, USA

9:00

Meet the Professor: Emerging Technologies

Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Kaarst, Germany

9:30

Meet the Professor: Algorithms for AIDs

Marc Breton, PhD
University of Virginia, Charlottesville, Virginia, USA

10:00

Product Theater: Dexcom Presents: Innovations and Opportunities with Dexcom Real-Time API and Connected Systems

Matt Vogel
Senior Director Marketing, Strategic Partnerships

Nate Ahuna
Associate Director of Global Business Development and Strategic Partnerships

Dr. Anand K. Iyer
Chief Strategy Officer, Welldoc

11:00

Product Theater: Medtronic Presents: Smart Insulin Management: The Present and Future

Robert Vigersky, MD
Chief Medical Officer, Medtronic Diabetes

David Dunleavy
Vice President Portfolio Management, Medtronic Diabetes

11:30

Product Theater: Glytec Presents: eGlycemic Management System: Revolutionizing Glycemic Management by Uniting Teams around Patient Safety

12:00

Product Theater: Abbott Presents: Comparative Effects of the FreeStyle Libre Portfolio & Dexcom Systems

Eden Miller, DO
Diplomat of American Board of Obesity Medicine, Diabetes and Obesity Care, Bend, OR

Thursday, November 4, 2021

WORKSHOP A: NEW TECHNOLOGIES FOR GLUCOSE MONITORING

PANEL 1:  BLOOD GLUCOSE MONITORING

8:00

Moderators:

Piotr Ladyzynski, PhD, DSc
Nalecz Institute of Biocybernetics and Biomedical Engineering Polish Academy of Sciences, Warsaw, Poland

John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, United Kingdom

8:05

Noninvasive Glucose Monitoring

Andreas Thomas, PhD
AGDT (Working group of Diabetes Technology), Germany, Ulm, Germany

8:20

Future of Blood Glucose Monitoring

Marcel Gmünder, JD
Roche Diagnostics International AG, Basel, Switzerland

8:35

Polypharmacy, Interfering Substances and Glucose Monitoring Devices

Elizabeth Holt, MD, FACE
LifeScan Global Corporation, Malvern, Pennsylvania, USA

8:50

Innovative Glucose Sensing Principles - Optical Transmission Absorbance System and Open Circuit Potential-Based Sensing System

Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

9:05

Q&A / Panel Discussion

9:30

Break

PANEL 2: CONTINUOUS GLUCOSE MONITORING

9:55

Moderators:

Thanh Hoang, DO, FACP, FACE
Walter Reed National Military Medical Center, Bethesda, Maryland, USA

Jennifer Sherr, MD, PhD
Yale University, New Haven, Connecticut, USA

10:00

Traceability for BGM and CGM

Guido Freckmann, MD
Institute for Diabetes Technology GmbH, Ulm, Germany

10:15

Abbott Technology

Marc Taub, PhD
Abbott Diabetes Care, Alameda, California, USA

10:27

Dexcom Technology

Peter Simpson, MS
DexCom, Inc., San Diego, California, USA

10:39

WaveForm Technology

Mihailo Rebec, PhD
WaveForm Technologies, Wilsonville, Oregon, USA

10:51

Medtronic Technology

Robert Mucic, PhD
Medtronic Diabetes, Northridge, California, USA

11:03

Nemaura Technology

Faz Chowdhury, PhD
Nemaura Medical, Loughborough, UK

11:15

Ascensia Technology

Francine Kaufman, MD
Senseonics, Inc., Germantown, Maryland, USA

11:27

Q&A / Panel Discussion

11:40

Lunch

WORKSHOP B: CONNECTED HEALTH

PANEL 1: WHICH NOVEL SENSORS WILL BECOME ESTABLISHED FOR DIABETES?

12:40

Moderators:

Eda Cengiz, MD, MHS, FAAP
University of California, San Francisco, San Francisco, California, USA

Hazhir Teymourian, PhD
University of California, San Diego, San Diego, California, USA

12:45

Smart Pens

Søren Smed Østergaard, MS
Novo Nordisk, Copenhagen, Denmark

13:00

Wireless Blood Pressure Monitoring

Dessi Zaharieva, PhD
Stanford University, Palo Alto, California, USA

13:15

Apps for Estimating Food Intake

Ricardo Gutierrez-Osuna, PhD
Texas A&M University, College Station, Texas, USA

13:30

Foot Sensors

David Armstrong, DPM, MD, PhD
University of Southern California, Los Angeles, California, USA

13:45

Continuous Ketone Monitoring

Kristin Castorino, DO, BC-ADM
Sansum Diabetes Research Institute, Santa Barbara, California, USA

14:00

Q&A

14:20

Break

PANEL 2: CAN DIRECT-TO-CONSUMER TELEHEALTH PROGRAMS MEET LOCAL NEEDS?

14:45

Moderators:

Andjela Drincic, MD, FACP
University of Nebraska, Omaha, Nebraska, USA

Barry Ginsberg, MD, PhD
Diabetes Technology Consultants, Arlington, Virginia, USA

14:50

Panel Discussion

Shailendra Bajpai, MBBS, MD
Becton Dickinson Greater Asia, Singapore

Ronald Dixon, MD
CareHive, Austin, Texas, USA

Leslie Eiland, MD
University of Nebraska Medical Center, Omaha, Nebraska, USA

Michelle Griffith, MD
Vanderbilt University, Nashville, Tennessee, USA

Gretchen Zimmerman, RD, CDCES
Vida Health, San Francisco, California, USA

16:05

Q&A

16:30

End of Workshop

Friday, November 5, 2021

8:00

Introduction

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05

Keynote Presentation: Technology and the ADA

Robert Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA

SESSION 1: BEST METRICS FOR GLYCEMIA USING CGM

8:30

Moderators:

Will Cefalu, MD
NIDDK/NIH, Bethesda, Maryland, USA

Claudio Cobelli, PhD
University of Padova, Padova, Italy

8:35

Clinical Importance of Glycemic Variability

David Rodbard, MD
Biomedical Informatics Consultants LLC, Potomac, Maryland, USA

8:45

Time in Range is Predictive of Diabetic Vascular Complications

Roy Beck, MD, PhD
Jaeb Center for Health Research, Tampa, Florida, USA

8:55

The New Composite Dysglycemia Index for Assessing CGMs

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

9:05

Using Time in Range to Optimize and Personalize Diabetes Management

Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota, USA

9:15

Q&A / Panel Discussion

9:40

End of Session

SESSION 2: SOFTWARE FOR DIABETES

9:40

Moderators:

David Ahn, MD
Mary & Dick Allen Diabetes Center at Hoag, Newport Beach, California, USA

Guillermo Umpierrez, MD
Emory University, Atlanta, Georgia, USA

Presentation of Diabetes Technology Leadership Award

Presentation of Artificial Pancreas Award

9:45

Insulin Dosing Software

Moshe Phillip, MD
National Center for Childhood Diabetes
Schneider Children's Medical Center of Israel, Petah Tikva, Israel

10:00

Hurdles to Bringing Digital Health Technologies to the Market

Chris Boulton, BSc
Sanofi, Bridgewater, New Jersey, USA

10:15

Getting the Most Out of the EHR

Juan Espinoza, MD
Children’s Hospital Los Angeles, USC, Los Angeles, California, USA

10:30

Q&A / Panel Discussions

10:50

Break

SESSION 3: REGULATION OF DIABETES TECHNOLOGY

11:15

Moderators:

Alexander Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA

Alberto Gutierrez, PhD
NDA Partners, LLC, Bethesda, Maryland, USA

11:20

Diabetes Hardware and Software

Naomi Schwartz, MS
FDA, Silver Spring, Maryland, USA

11:35

Medical Device Cybersecurity

Kevin Fu, PhD
FDA, Silver Spring, Maryland, USA

11:50

Privacy of Diabetes Devices

Alice Leiter, JD
EHealth Initiative, Washington DC, USA

12:05

Q&A / Panel Discussion

12:25

Lunch

SESSION 4: DIABETES DATA SCIENCE

13:25

Moderators:

Guillermo Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland, USA

 Riccardo Bellazzi, PhD
 University of Pavia, Pavia, Italy

13:30

Diabetes Data Science

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

13:45

Artificial Intelligence for Diabetes

Martina Vettoretti, PhD
University of Padova, Padova, Italy

14:00

Machine Learning for Diabetes

Josep Vehi, PhD
University of Girona, Girona, Spain

14:15

Q&A / Panel Discussion

14:30

End of Session

SESSION 5: ARTIFICIAL PANCREAS: SCIENTIFIC ADVANCES

14:30

Moderators:

Wayne Bequette, PhD
Rensselaer Polytechnic Institute, Troy, New York, USA

Peter Jacobs, PhD
Oregon Health and Science University, Portland, Oregon, USA

14:35

Use of an Artificial Pancreas during Stress Disturbances

Frank Doyle, PhD, CPGS
Dean, Harvard University John A. Paulson School of Engineering & Applied Sciences, Cambridge, Massachusetts, USA

14:47

Using an Online Disturbance Rejection and Anticipation System to Reduce Hyperglycemia in a Fully Closed-Loop Artificial Pancreas System

Marc Breton, PhD
University of Virginia, Charlottesville, Virginia, USA

14:59

Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems

Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA

15:11

Q&A / Panel Discussion

15:30

Break

SESSION 6A: PATIENT PANEL

15:55

Moderators:

Bruce Buckingham, MD
Stanford University, Palo Alto, California, USA

Laura Pickett, MD
International Diabetes Center, Minneapolis, Minnesota, USA

16:00

Patient Panel (Tandem, Medtronic, Insulet, Diabeloop)

16:20

End of Panel

SESSION 6B: ARTIFICIAL PANCREAS: COMPARISON OF PRODUCTS

16:20

Moderators:

Ananda Basu, MBBS, MD, FRCP (UK)
University of Virginia, Charlottesville, Virginia, USA

Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA

16:25

Features of Insulet Omnipod 5

Sue Brown, MD
University of Virginia Health, Charlottesville, Virginia, USA

16:35

Features of Medtronic FLAIR

Elvira Isganaitis, MD, MPH
Joslin Diabetes Center Harvard University, Boston, Massachusetts, USA

16:45

Features of Tandem Control-IQ

Paul Wadwa, MD
University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

16:55

Features of Beta Bionics iLet Bionic Pancreas

Steven Russell, MD, PhD
Massachusetts General Hospital Harvard University, Boston, Massachusetts, USA

17:05

Features of CamAPS FX

Roman Hovorka, PhD, FMedSci
University of Cambridge, Cambridge, UK

17:15

Q&A / Panel Discussion

17:35

End of Session

Saturday, November 6, 2021

SESSION 7: NOVEL INSULINS

8:00

Moderators:

Gerold Grodsky, PhD
University of California, San Francisco, San Francisco, USA

Elias Spanakis, MD
University of Maryland, Baltimore, Maryland, USA

Presentation of Student Research Awards

8:05

Student Speaker

Rahul Narayan, MS
Oregon Health & Science University, Portland, Oregon, USA

8:15

New Insulins

Tim Heise, MD
Profil, Neuss, Germany

8:25

Smart Glucose-Responsive Insulins

Michael Weiss, MD, PhD, MBA
Indiana University School of Medicine, Indianapolis, Indiana, USA

8:35

Update on New Glucagon Products

Anne Peters, MD
Keck School of Medicine of USC, Los Angeles, California, USA

8:45

Heat Stability of Various Insulin Types

Leonardo Scapozza, PhD
University of Geneva, Geneva, Switzerland

8:55

Q&A / Panel Discussion

9:10

End of Session

SESSION 8: INSULIN DELIVERY

9:10

Moderators

Umesh Masharani, MD
University of California, San Francisco, San Francisco, California, USA

Anant Nigam, MD, FRCP
Nigam Diabetes Centre, Jaipur, India

9:15

Novel Needles

Teresa Oliveria, PharmD
BD, Franklin Lakes, New Jersey, USA

9:30

Novel Insulin Delivery Systems

Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA

9:45

Novel Infusion Sets

Robert Vigersky, MD
Medtronic Diabetes, Northridge, California, USA

10:00

Forget Diabetes: A Novel Automated Insulin Delivery System

Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany

10:15

Smartwatch- and Smartphone-Mediated Cell-Based Diabetes Control

Maysam Mansouri, PhD
ETH Zürich, D- BSSE, Basel, Switzerland

10:30

Q&A / Panel Discussion

10:55

Break

SESSION 9: SKIN TRAUMA DUE TO DIABETES DEVICES

11:20

Moderators:

Halis Akturk, MD
University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, Colorado, USA

Mohammed Al-Sofiani, MBBS, MSc
King Saud University, Riyadh, Saudi Arabia

11:25

Bruising

Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Kaarst, Germany

11:40

Allergic Reactions to Adhesives

Jannet Svensson, MD, PhD
Department of Pediatrics and Adolescent Medicine, Herlev and Gentofte Hospital, Herlev, Denmark

11:55

Preserving Skin Integrity with Wearable Diabetes Devices

Cari Berget, RN, MPH, CDCES
University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, Colorado, USA

12:10

Advances in Adhesives

Naunihal Virdi, MD
Abbott Diabetes Care, Alameda, California, USA

12:25

Q&A / Panel Discussion

12:40

Lunch

SESSION 10: METABESITY: PREVENTING METABOLIC DETERIORATION AND CHRONIC DISEASE

13:35

Moderators:

Brian Frier, BSc (Hons), MD, FRCP (Edin), FRCP (Glas)
University of Edinburgh, Edinburgh, Scotland

John Melish, MD
University of Hawaii, Honolulu, Hawaii, USA

13:40

Overview of Metabesity

Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia, USA

13:55

Repurposing Diabetes Sensors for Other Metabolic Diseases

Mark Clements, MD, PhD, CPI, FAAP
Children's Mercy Hospitals & Clinics, Kansas City, Missouri, USA

14:10

Use of CGM for Identifying Glucotypes

Michael Snyder, PhD
Stanford University, Stanford, California, USA

14:25

Q&A Panel Discussion

14:40

Break

SESSION 11: HOT TOPICS

15:05

Moderators:

Sarah Kim, MD
University of California, San Francisco, San Francisco, USA

Kayo Waki, MD, PhD, MPH
The University of Tokyo, Tokyo, Japan

15:10

Precision Diabetes

Louis Philipson, MD, PhD
University of Chicago, Chicago, Illinois

15:20

CGM in Type 2 Not on Insulin

Eugene Wright, MD
Charlotte Area Health Education Center, Charlotte, NC

15:30

Diversity in Diabetes Technology

Katharine Barnard-Kelly, PhD
BHR Ltd, Portsmouth, Hampshire, UK

15:40

Using Diabetes Technology in Pregnancy

Lynn Yee, MD, MPH
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

15:50

Green Diabetes

Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Neuss, Germany

16:00

Q&A / Panel Discussion

16:15

End of Session

LIVE DEMONSTRATION

16:15

Moderators:

Gu Eon Kang, PhD
University of Texas at Dallas, Dallas, Texas, USA

Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA

16:20

A Mobile App for Foot Selfies to Monitor Diabetic Foot Wounds

Mark Swerdlow, MS
University of Southern California, Los Angeles, California, USA

16:40

Closing Statements

16:45

End

Thursday, November 11, 2021

Virtual Poster Session

Session A

Moderators

Nestoras Mathioudakis, MD

Johns Hopkins University, Baltimore, Maryland, USA

 

Jessica Castle, MD

Oregon Health & Science University, Portland, Oregon, USA

 

8:30    Outpatient Full Closed-Loop Trial Using An Open-Source Remote Monitoring and Artificial Pancreas Platform

Fabricio Garelli, PhD et al.

Presented by Emilia Fushimi, Eng.

 

8:34    Significant Reductions in Adverse Events and Hospitalizations with Control-IQ Technology in Adults with Type 1 Diabetes: Data from the CLIO Study

Jordan E. Pinsker, MD et al.

 

8:38    Impact of Real-World MiniMed™ 670G System Use on Glycemic Outcomes in the United States

Siddharth Arunachalam, MSc et al.

 

8:42    Real-World Outcomes of the MiniMedTM 780G System when Used with Optimal Settings

Arcelia Arrieta, MS et al.

Presented by Ohad Cohen, MD

 

8:46    Current Technology Use in Pediatric Patients with Type 1 Diabetes: An Equity-Focused Analysis

Katie Fogle, BS

 

8:50    Higher Dose of Inhaled Technosphere Insulin Provides Significant Reduction in Post Prandial Glucose Excursions, Without Hypoglycemia

Kevin Kaiserman, MD et al.

 

8:54    Q&A / Panel Discussion

 

 

Session B

Moderators

Julia Mader, MD, PhD

Medical University of Graz, Graz, Austria

 

Boris Kovatchev, PhD

University of Virginia, Charlottesville, Virginia, USA

 

9:15    Hyperoptimized DeepLearning Model For Glucose Prediction On DBLG1

Hector Romero-Ugalde, PhD et al.

 

9:19    Predicting Postprandial Glucose Excursions with Macronutrient Content using an Interpretable Random Forest Augmented by a Digital Twin ODE Model

Rahul Narayan, MS et al.

 

9:23    In Silico Trial to Quantitatively Measure How Much Different Behavioural Factors Influence Time in Hypoglycemia in Type 1 Diabetes Management

Chiara Roversi, MS et al.

 

9:27    Importance of Accounting for Correlation Among Noise Samples when Filtering CGM Data: A Simulation Study

Ilaria Siviero, MS et al.

Presented by Nunzio Camerlingo, MSc

 

9:31    Evaluation of the Safety and Efficacy of the Lalani Insulin Infusion Protocol

Benjamin Lalani et al.

 

9:35    Generation of Realistic Virtual Diabetes Patients Using a Pix2Pix GAN: In Pursuit of AI-based Diabetes Simulator

Omer Mujahid, MSc et al.

 

9:39    Q&A / Panel Discussion

 

Session C

Moderators

Boris Mankovksy, MD, PhD

Institute of Endocrinology, Kiev, Ukraine

 

Mike McShane, PhD

Texas A&M University, College Station, Texas, USA

 

10:00  Post-Market Clinical Surveillance of OneTouch Ultra® Plus Blood Glucose Test Strips

Steven Setford, PhD et al.

 

10:04  Clinical Evaluation of the Lumee™ Glucose System - A Fluorescence-Based long-term continuous glucose sensor

Ulrike Kamecke, Dipl-Ing (FH) et al.

 

10:08  Wearable Electrochemical Platform for Glucose Monitoring and Diabetes Management

Russell Potts, PhD et al.

 

10:12  Point-of-Care Insulin Monitoring Using Electrochemical Sensing

Clara Stroh et al.

 

10:16  1,5-Anhydroglucitol is an Independent Predictor of Mortality in Patients with COVID-19

Eric Button, MS, MBA et al.

 

10:20  Unsupervised Anomaly Detection Algorithms to Identify Compression Artifacts in Continuous Glucose Monitoring

Elena Idi, MS et al.

 

10:24  Q&A / Panel Discussion

 

Session D

Moderators

Hubert Vesper, PhD

Centers for Disease Control and Prevention, Atlanta, Georgia, USA

 

Lori Laffel, MD, MPH

Joslin Diabetes Center Harvard Medical School, Boston, Massachusetts, USA

 

10:45  Improvements in Hypoglycemia and HbA1c with RT-CGM Adoption: Results from the COACH Study

Stayce Beck, PhD et al.

 

10:49  Long-Term (7-Year) Glycemic Outcomes with Continuous Glucose Monitoring (CGM) Initiation within First Year of Type 1 Diabetes (T1D) Diagnosis

Anagha Champakanath, MBBS et al.

 

10:53  Relationship between Time in Range, Glycemic Variability Metrics and Daily Scan Rate in Children with Type 1 Diabetes

Pietro Bosoni, MSc et al.

 

10:57  A Data-Driven Approach to Predict Carbohydrate Counting Errors in Diabetes Management

Sahaj Shah, BA et al.

 

11:01  Identifying Patients at High Risk for Cystic Fibrosis Related Diabetes through the use of the Freestyle LibrePro CGM

Jeniece Ilkowitz, RN, MA, CDE et al.

 

11:05  Upcycling of Used CGM to a Cool Chain Monitor for Insulin

Thomas Wuttke, Dipl.-Ing. et al.

 

11:09  Q&A / Panel Discussion

 

Session E

Moderators

Francisco Pasquel, MD, MPH

Emory University, Atlanta, Georgia, USA

 

Sultan Meo, MD, PhD, FRCP

King Saud University, Riyadh, Saudi Arabia

 

11:30  Phenolic Preservatives, Present in Commercial Insulins, Trigger Inflammation at Infusion Sites via Mast Cell Activation

Shereen Kesserwan, MS et al.

 

11:34  Rate of Unexplained Hyperglycemia and Infusion Set Occlusion: Medtronic Extended Infusion Set (EIS) Pivotal Trial and 3-day Infusion Set Study Comparison

Sarnath Chattaraj, PhD et al.

 

11:38  Potential Cost Savings from a Reduction in Sensor-detected Severe Hypoglycemia Among Users of the InPen Smart Insulin Pen System

Albert Chien, MA, MPH et al.

 

11:42  User Experiences with an Insulin Pen Platform

April Taylor, MSN, CNS et al.

 

11:46  Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Type 1 and Type 2 Diabetes Patients

Rachel S. Newson, PhD et al.

 

11:50  Determining losses in Jet-Injection Subcutaneous Insulin delivery

Alex McHugh, BE (Hons) et al.

 

11:54  Q&A / Panel Discussion

 

Session F

Moderators

Wei-An (Andy) Lee, DO

LAC+USC Medical Center, Los Angeles, California, USA

 

Jing Wang, PhD, MPH, RN, FAAN

Florida State University, Tallahassee, Florida, USA

 

12:15  Increased Time-in-Range after Meals When Using the SNAQ App

David Haldimann, MSc et al.

Presented by Aurelian Briner, MA

 

12:19  Representing Type 1 Diabetes Device Data Using CDISC Standards

John Owen, BSc et al.

Presented by Rebecca Baker, MS, MHA, BSN

 

12:23  Development of Self-Management Behavior Scores and Profiles with Digital Health Data

Michelle Dugas, PhD et al.

 

12:27  “Pre-Ramadan” Telemedicine: Effect on Fasting Experience & Glycemic Control during Ramadan in People with Type 1 Diabetes

Sahar Alharthi, MBBS et al.

 

12:31  The Effects of One Drop Digital Program on Glucose Control in Employees with Type 1 and 2 Diabetes

Lindsay Sears, PhD et al.

 

12:35  Virtual Care in the COVID-19 Era: Assessing Telemedicine Experiences among Diabetes Care and Education Specialists

Evelyn Cox, BA et al.

 

12:39  Q&A / Panel Discussion